Vivos Inc (RDGL)

[User-499230]

An update on DCGI's decision to allow Vivos to conduct human clinical trials towards commercialization in India likely in mid October 2025 to mid November 2025.

If...IF...Vivos needs to do more human clinical trials in India to gain IDE approval (I'm still NOT 100% sure if that is the case) than Drugs Controller General of India (DCGI) approval and Vivos Scientific India operations in GENERAL are significantly more important to Vivos than IDE approval at this point.

We know that Vivos has been pursuing an expanded permit from the DCGI to conduct clinical trials for commercial applications in India since at least 30 June 2025 based on the.

DCGI must decide to approve or decline Vivos' application within 90 working days from the application receipt, based on online sources.

An update on DCGI's decision to allow Vivos to conduct human clinical trials towards commercialization in India likely in mid October 2025 to mid November 2025.

--

GO VIVOS INDIA GO!!